Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bismuth-sensitive bacterial and mucosal targets represent a diverse group of molecular sites that mediate the therapeutic effects of bismuth salts in treating gastrointestinal disorders. These targets include essential bacterial enzymes such as urease and F1-ATPase, which are critical for the survival of Helicobacter pylori, as well as bacterial cell wall components and iron-acquisition siderophores (PubMed, 2015; Nature Microbiology, 2024). On the host side, bismuth ions interact with gastric mucosal glycoproteins to precipitate and form a protective physical barrier over ulcerated tissue, shielding it from the aggressive effects of gastric acid and pepsin (NIH, 2025; droracle.ai, 2026). Furthermore, bismuth stimulates the endogenous synthesis of prostaglandins and bicarbonate, which enhance the mucosal defense and promote tissue repair (Semanticscholar.org, 2025). In formulations like bismuth subsalicylate, the salicylate component targets cyclooxygenase enzymes to provide additional anti-inflammatory and antisecretory benefits (patsnap.com, 2024). This multi-pronged mechanism makes bismuth salts effective in eradicating infections, protecting the gut lining, and managing symptoms of diarrhea and dyspepsia (WebMD, 2025).
Bismuth salts act via a multi-targeted approach: they exert direct bactericidal effects by inhibiting essential enzymes such as urease, alcohol dehydrogenase, and F1-ATPase, and by disrupting iron uptake through the blocking of siderophores in pathogens like Helicobacter pylori (PubMed, 2015; Nature Microbiology, 2024). Simultaneously, they provide mucosal protection by binding to gastric glycoproteins to form a physical barrier over ulcers, stimulating prostaglandin and bicarbonate secretion, and neutralizing bacterial toxins (NIH, 2025; droracle.ai, 2026). In subsalicylate forms, they also inhibit cyclooxygenase enzymes to provide anti-inflammatory and antisecretory effects (patsnap.com, 2024; Wikipedia, 2024).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bismuth-sensitive bacterial and mucosal targets.